Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07285863 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

StatusRecruiting
PhasePhase 4
Started2026-03-11
View on ClinicalTrials.gov ↗

Amendment history

2026-07-03
Study Status, Arms and Interventions v4
Re-verified, no change to tracked fields
2026-04-27
Study Status, Contacts/Locations v3
Recruitment opened
Primary completion pushed: 2027-01 → 2027-03
Completion pushed: 2028-01 → 2028-03
Start dateestimated 2026-02→confirmed 2026-03-11
Study sitesdetails revised at 1 of 1 site
2026-02-03
Study Status, Contacts/Locations v2
Start date2026-01→2026-02
2025-12-16
Study Status, Outcome Measures v1
Primary endpoints1 to 4 entries
Pancreatic Fluid ElectrolyteBicarbonate Composition Pancreatic Fluid Chloride Composition Pancreatic Fluid Potassium Composition Pancreatic Fluid Sodium Composition
2025-12-11
Original filing
Mayo Clinic
1,015 trials monitored
See 115 trials at risk
The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
Trial Details
NCT Number NCT07285863
Lead Sponsor Mayo Clinic
Collaborators: ChiRhoClin, Inc.
Conditions Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Enrollment 24 participants
Start Date 2026-03-11
Primary Completion 2027-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-07